High expression of CD166 surface marker was only reported in osteoarthritis (OA) MSCs showing increased expression of cartilage markers RUNX2 and COL10A1. It was hypothesized that OA-MSCs drive the OA progression [32]. Here, RUNX2 is linked to osteoarthritis.